Indocyanine green SPY elite-assisted sentinel lymph node biopsy in cutaneous melanoma

Plastic and Reconstructive Surgery

Volumn 133, Issue 4, 2014, Pages 914-922

  Korn, Jason M ^a   Tellez Diaz, Alejandra ^a   Bartz Kurycki, Marisa ^a   Gastman, Brian ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; FLUORESCENT DYE; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; EQUIPMENT; FEASIBILITY STUDY; FEMALE; HEAD AND NECK TUMOR; HUMAN; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

ADULT; AGED; COLORING AGENTS; FEASIBILITY STUDIES; FEMALE; FLUORESCENT DYES; HEAD AND NECK NEOPLASMS; HUMANS; INDOCYANINE GREEN; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 84898735055     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0000000000000006     Document Type: Article

References (25)

1. Gershenwald JE, Ross MI. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med. 2011;364: 1738-1745.
2. Valsecchi ME, Silbermins D, de Rosa N, Wong SL, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: A meta-analysis. J Clin Oncol. 2011;29: 1479-1487.
3. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127: 392-399.
4. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-339; discussion 340.
5. Morton DL, Cochran AJ, Thompson JF, et al.; Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302-311; discussion 311.
6. Sondak VK, Zager JS. Who is to blame for false-negative sentinel node biopsies in melanoma? Ann Surg Oncol. 2010;17: 670-673.
7. Wong SL, Balch CM, Hurley P, et al.; American Society of Clinical Oncology; Society of Surgical Oncology. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol. 2012;30: 2912-2918.
8. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol. 2006;13: 1655-1663.
9. Carlson GW, Page AJ, Cohen C, et al. Regional recurrence after negative sentinel lymph node biopsy for melanoma. Ann Surg. 2008;248: 378-386.
10. Karim RZ, Scolyer RA, Li W, et al. False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology. Ann Surg. 2008;247: 1003-1010.
11. Caracò C, Marone U, Celentano E, Botti G, Mozzillo N. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol. 2007;14: 2662-2667.
12. Lam TK, Uren RF, Scolyer RA, Quinn MJ, Shannon KF, Thompson JF. False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: The value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Res. 2009;19: 94-99.
13. Dengel LT, More MJ, Judy PG, et al. Intraoperative imaging guidance for sentinel node biopsy in melanoma using a mobile gamma camera. Ann Surg. 2011;253: 774-778.
14. Itakura E, Huang RR, Wen DR, Cochran AJ. "Stealth" melanoma cells in histology-negative sentinel lymph nodes. Am J Surg Pathol. 2011;35: 1657-1665.
15. Gilmore DM, Khullar OV, Gioux S, et al. Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann Surg Oncol. 2013;20: 2357-2363.
16. Marshall MV, Rasmussen JC, Tan IC, et al. Near-infrared fluorescence imaging in humans with indocyanine green: A review and update. Open Surg Oncol J. 2010;2: 12-25.
17. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F. Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer. J Surg Oncol. 2012;106: 41-45.
18. Fujiwara M, Mizukami T, Suzuki A, Fukamizu H. Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: Preliminary experience. J Plast Reconstr Aesthet Surg. 2009;62:e373-e378.
19. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27: 6199-6206.
20. van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma. Br J Dermatol. 2013;168: 93-98.
21. Wrightson WR, Wong SL, Edwards MJ, et al.; Sunbelt Melanoma Trial Study Group. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol. 2003;10: 676-680.
22. Marone U, Aloj L, Di Monta G, Caracò C. Lymphoscintigraphy defines new lymphatic pathways from cutaneous melanoma site: Clinical implications and surgical management. Radiol Res Pract. 2011;2011:817043.
23. de Rosa N, Lyman GH, Silbermins D, et al. Sentinel node biopsy for head and neck melanoma: A systematic review. Otolaryngol Head Neck Surg. 2011;145: 375-382.
24. Veenstra HJ, Klop WM, Speijers MJ, et al. Lymphatic drainage patterns from melanomas on the shoulder or upper trunk to cervical lymph nodes and implications for the extent of neck dissection. Ann Surg Oncol. 2012;19: 3906-3912.
25. Namikawa K, Tsutsumida A, Tanaka R, Kato J, Yamazaki N. Limitation of indocyanine green fluorescence in identifying sentinel lymph node prior to skin incision in cutaneous melanoma. Int J Clin Oncol. 2014;19: 198-203.